DexCom Inc (DXCM)

Debt-to-capital ratio

Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Long-term debt US$ in thousands 2,434,200 2,432,400 2,430,600 1,198,500 1,197,700 1,968,800 1,967,300 1,965,900 1,702,700 1,703,500 1,710,700 1,688,800 1,667,200 1,645,800 1,658,800 1,072,400 1,059,700 1,047,100 1,034,700 1,022,400
Total stockholders’ equity US$ in thousands 2,068,600 2,267,900 2,100,400 2,233,000 2,131,800 1,824,500 2,255,900 2,189,300 2,042,100 1,912,000 1,754,700 1,644,800 1,551,900 1,499,300 1,353,900 934,500 882,600 764,300 688,300 668,600
Debt-to-capital ratio 0.54 0.52 0.54 0.35 0.36 0.52 0.47 0.47 0.45 0.47 0.49 0.51 0.52 0.52 0.55 0.53 0.55 0.58 0.60 0.60

December 31, 2023 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $2,434,200K ÷ ($2,434,200K + $2,068,600K)
= 0.54

The debt-to-capital ratio of Dexcom Inc has shown some fluctuation over the past eight quarters. In Q4 2023, the ratio stood at 0.55, slightly higher than in Q3 2023 when it was 0.54. Comparing Q4 2023 to the same quarter in the previous year (Q4 2022), the ratio has increased from 0.49 to 0.55.

Overall, the trend in the debt-to-capital ratio indicates that the company has been gradually increasing its reliance on debt to finance its operations and investments. A rising debt-to-capital ratio can signify increasing financial leverage and potential risk, as higher debt levels may lead to higher interest payments and reduced financial flexibility. Investors and creditors typically monitor this ratio closely to assess the company's ability to meet its debt obligations and manage financial risks effectively.


Peer comparison

Dec 31, 2023


See also:

DexCom Inc Debt to Capital (Quarterly Data)